$CNTX to me, this is extremely solid result with p value <0.05 statistical very significant result, again, this drug is only full PR antagonist in the market, and around 70% of all females related cancers having PR +, it is solution with combined ER and PR solution which will be optimal, so to me, this worth long term hold, just wait for summer with their 3/5 phase 2 results released, boom!!
3
4
4 Likes